Compounds > 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate
Page last updated: 2024-09-03

5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate and kainic acid

5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate has been researched along with kainic acid in 1 studies

Compound Research Comparison

Studies
(5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate)		Trials
(5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate)		Recent Studies (post-2010)
(5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate)		Studies
(kainic acid)		Trials
(kainic acid)		Recent Studies (post-2010) (kainic acid)
19009,54031,775

Protein Interaction Comparison

ProteinTaxonomy5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate (IC50)kainic acid (IC50)
Glutamate receptor 1Rattus norvegicus (Norway rat)4.2857
Glutamate receptor 2Rattus norvegicus (Norway rat)4.2857
Glutamate receptor 3Rattus norvegicus (Norway rat)4.2857
Glutamate receptor 4Rattus norvegicus (Norway rat)4.2857
Glutamate receptor ionotropic, kainate 1Rattus norvegicus (Norway rat)0.0126
Glutamate receptor ionotropic, kainate 1Homo sapiens (human)0.077
Glutamate receptor ionotropic, kainate 2Rattus norvegicus (Norway rat)0.0126
Glutamate receptor ionotropic, kainate 3Rattus norvegicus (Norway rat)0.0126
Glutamate receptor ionotropic, kainate 4Rattus norvegicus (Norway rat)0.0126
Glutamate receptor ionotropic, kainate 2Homo sapiens (human)0.077
Glutamate receptor ionotropic, kainate 3Homo sapiens (human)0.077
Glutamate receptor ionotropic, kainate 4Homo sapiens (human)0.077
Glutamate receptor ionotropic, kainate 5Homo sapiens (human)0.077
Glutamate receptor ionotropic, kainate 5Rattus norvegicus (Norway rat)0.0126

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arvin, B; Meldrum, BS; Moncada, CR1

Other Studies

1 other study(ies) available for 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate and kainic acid

ArticleYear
The pyrimidine derivative BW 1003C87 protects against excitotoxic lesions induced by kainate in the rat striatum.
    Neuroscience letters, 1994, Sep-26, Volume: 179, Issue:1-2

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Hippocampus; Kainic Acid; Lamotrigine; Male; Neostriatum; Nervous System Diseases; Neural Pathways; Pyrimidines; Rats; Rats, Wistar; Triazines

1994